Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system

Journal of Nutritional Biochemistry

Volumn 24, Issue 12, 2013, Pages 2110-2118

  Okatan, Esma Nur ^a   Tuncay, Erkan ^a   Turan, Belma ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Calcium calmodulin kinase; Calcium spark; Cellular redox regulation; Glutathione; Heart; Protein kinase A

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; RYANODINE RECEPTOR 2; SELENATE; SELENIUM; STREPTOZOCIN; THIOREDOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DRUG EFFECT; ELECTROSTIMULATION; GENE FUNCTION; HEART FUNCTION; HYPERGLYCEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAT; TREATMENT DURATION;

RATTUS;

CALCIUM CALMODULIN KINASE; CALCIUM SPARK; CELLULAR REDOX REGULATION; GLUTATHIONE; HEART; PROTEIN KINASE A;

ANIMALS; CALCIUM; CARDIOMYOPATHIES; CARDIOTONIC AGENTS; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; LIPID PEROXIDATION; MALE; MYOCYTES, CARDIAC; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHORYLATION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SELENIC ACID; TACROLIMUS BINDING PROTEINS; THIOREDOXINS;

EID: 84887613648     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.08.002     Document Type: Article

References (62)

1. Stadtman E.R., Levine R.L. Protein oxidation. Ann N Y Acad Sci 2000, 899:191-208.
2. Telci A., Cakatay U., Salman S., Satman I., Sivas A. Oxidative protein damage in early stage type 1 diabetic patients. Diabetes Res Clin Pract 2000, 50(3):213-223.
3. Odetti P., Garibaldi S., Noberasco G., Aragno I., Valentini S., Traverso N., Marinari U.M. Levels of carbonyl groups in plasma proteins of type 2 diabetes mellitus subjects. Acta Diabetol 1999, 36(4):179-183.
4. Wold L.E., Ceylan-Isik A.F., Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin 2005, 26(8):908-917.
5. Gumieniczek A., Hopkala H., Wojtowicz Z., Nikolajuk J. Changes in antioxidant status of heart muscle tissue in experimental diabetes in rabbits. Acta Biochim Pol 2002, 49(2):529-535.
6. Nishinaka Y., Nakamura H., Masutani H., Yodoi J. Redox control of cellular function by thioredoxin; a new therapeutic direction in host defence. Arch Immunol Ther Exp (Warsz) 2001, 49(4):285-292.
7. Wohaieb S.A., Godin D.V. Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 1987, 36(9):1014-1018.
8. Ayaz M., Turan B. Selenium prevents diabetes-induced alterations in [zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle. Am J Physiol Heart Circ Physiol 2006, 290(3):H1071-H1080.
9. Yaras N., Ugur M., Ozdemir S., Gurdal H., Purali N., Lacampagne A., Vassort G., Turan B. Effects of diabetes on ryanodine receptor ca release channel (ryr2) and ca2+ homeostasis in rat heart. Diabetes 2005, 54(11):3082-3088.
10. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2008, (2):CD007176.
11. Coppey L.J., Gellett J.S., Davidson E.P., Dunlap J.A., Lund D.D., Yorek M.A. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 2001, 50(8):1927-1937.
12. Tavazzi L., Tognoni G., Franzosi M.G., Latini R., Maggioni A.P., Marchioli R., Nicolosi G.L., Porcu M., Investigators G.-H. Rationale and design of the gissi heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail 2004, 6(5):635-641.
13. Thirunavukkarasu M., Penumathsa S.V., Koneru S., Juhasz B., Zhan L., Otani H., Bagchi D., Das D.K., Maulik N. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 2007, 43(5):720-729.
14. Li Y., Liu W., Xing G., Tian C., Zhu Y., He F. Direct association of hepatopoietin with thioredoxin constitutes a redox signal transduction in activation of ap-1/nf-kappab. Cell Signal 2005, 17(8):985-996.
15. Ulusu N.N., Turan B. Beneficial effects of selenium on some enzymes of diabetic rat heart. Biol Trace Elem Res 2005, 103(3):207-216.
16. Ayaz M., Ozdemir S., Ugur M., Vassort G., Turan B. Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys 2004, 426(1):83-90.
17. Sen C.K., Packer L. Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr 2000, 72(2 Suppl):653S-669S.
18. Sen C.K., Khanna S., Reznick A.Z., Roy S., Packer L. Glutathione regulation of tumor necrosis factor-alpha-induced nf-kappa b activation in skeletal muscle-derived l6 cells. Biochem Biophys Res Commun 1997, 237(3):645-649.
19. Tuncay E., Seymen A.A., Tanriverdi E., Yaras N., Tandogan B., Ulusu N.N., Turan B. Gender related differential effects of omega-3e treatment on diabetes-induced left ventricular dysfunction. Mol Cell Biochem 2007, 304(1-2):255-263.
20. Luan R., Liu S., Yin T., Lau W.B., Wang Q., Guo W., Wang H., Tao L. High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation. Cardiovasc Res 2009, 83(2):294-302.
21. Zschauer T.C., Matsushima S., Altschmied J., Shao D., Sadoshima J., Haendeler J. Interacting with thioredoxin-1-disease or no disease?. Antioxid Redox Signal 2013, 18(9):1053-1062.
22. Muller A.S., Most E., Pallauf J. Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic dbdb mice. J Anim Physiol Anim Nutr (Berl) 2005, 89(3-6):94-104.
23. Choi K.M., Zhong Y., Hoit B.D., Grupp I.L., Hahn H., Dilly K.W., Guatimosim S., Lederer W.J., Matlib M.A. Defective intracellular ca(2+) signaling contributes to cardiomyopathy in type 1 diabetic rats. Am J Physiol Heart Circ Physiol 2002, 283(4):H1398-H1408.
24. Xie H., Zhu P.H. Biphasic modulation of ryanodine receptors by sulfhydryl oxidation in rat ventricular myocytes. Biophys J 2006, 91(8):2882-2891.
25. Zima A.V., Blatter L.A. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006, 71(2):310-321.
26. Chen-Izu Y., Ward C.W., Stark W., Banyasz T., Sumandea M.P., Balke C.W., Izu L.T., Wehrens X.H. Phosphorylation of ryr2 and shortening of ryr2 cluster spacing in spontaneously hypertensive rat with heart failure. Am J Physiol Heart Circ Physiol 2007, 293(4):H2409-H2417.
27. Degrande S., Nixon D., Koval O., Curran J.W., Wright P., Wang Q., Kashef F., Chiang D., Li N., Wehrens X.H., Anderson M.E., Hund T.J., Mohler P.J. Camkii inhibition rescues proarrhythmic phenotypes in the model of human ankyrin-b syndrome. Heart Rhythm 2012, 9(12):2034-2041.
28. Kandilci H.B., Tuncay E., Zeydanli E.N., Sozmen N.N., Turan B. Age-related regulation of excitation-contraction coupling in rat heart. J Physiol Biochem 2011, 67(3):317-330.
29. Yaras N., Sariahmetoglu M., Bilginoglu A., Aydemir-Koksoy A., Onay-Besikci A., Turan B., Schulz R. Protective action of doxycycline against diabetic cardiomyopathy in rats. Br J Pharmacol 2008, 155(8):1174-1184.
30. Aydemir-Koksoy A., Bilginoglu A., Sariahmetoglu M., Schulz R., Turan B. Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. J Nutr Biochem 2010, 21(9):827-833.
31. Sozmen N.N., Tuncay E., Bilginoglu A., Turan B. Profound cardioprotection with timolol in a female rat model of aging-related altered left ventricular function. Can J Physiol Pharmacol 2011, 89(4):277-288.
32. Tuncay E., Zeydanli E.N., Turan B. Cardioprotective effect of propranolol on diabetes-induced altered intracellular ca2+ signaling in rat. J Bioenerg Biomembr 2011, 43(6):747-756.
33. Armstrong D., Browne R. The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 1994, 366:43-58.
34. Kumar S., Holmgren A. Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by tpa, a calcium ionophore and other tumor promoters. Carcinogenesis 1999, 20(9):1761-1767.
35. Ayaz M., Can B., Ozdemir S., Turan B. Protective effect of selenium treatment on diabetes-induced myocardial structural alterations. Biol Trace Elem Res 2002, 89(3):215-226.
36. Shao C.H., Rozanski G.J., Patel K.P., Bidasee K.R. Dyssynchronous (non-uniform) ca2+ release in myocytes from streptozotocin-induced diabetic rats. J Mol Cell Cardiol 2007, 42(1):234-246.
37. Mariappan N., Elks C.M., Sriramula S., Guggilam A., Liu Z., Borkhsenious O., Francis J. Nf-kappab-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res 2010, 85(3):473-483.
38. Turan B., Saini H.K., Zhang M., Prajapati D., Elimban V., Dhalla N.S. Selenium improves cardiac function by attenuating the activation of NF-kappab due to ischemia-reperfusion injury. Antioxid Redox Signal 2005, 7(9-10):1388-1397.
39. Yamawaki H., Berk B.C. Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels. Curr Opin Nephrol Hypertens 2005, 14(2):149-153.
40. World C.J., Yamawaki H., Berk B.C. Thioredoxin in the cardiovascular system. J Mol Med (Berl) 2006, 84(12):997-1003.
41. Wang S.Q., Song L.S., Xu L., Meissner G., Lakatta E.G., Rios E., Stern M.D., Cheng H. Thermodynamically irreversible gating of ryanodine receptors in situ revealed by stereotyped duration of release in ca(2+) sparks. Biophys J 2002, 83(1):242-251.
42. Yano M., Yamamoto T., Ikemoto N., Matsuzaki M. Abnormal ryanodine receptor function in heart failure. Pharmacol Ther 2005, 107(3):377-391.
43. Terentyev D., Gyorke I., Belevych A.E., Terentyeva R., Sridhar A., Nishijima Y., De Blanco E.C., Khanna S., Sen C.K., Cardounel A.J., Carnes C.A., Gyorke S. Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum ca2+ leak in chronic heart failure. Circ Res 2008, 103(12):1466-1472.
44. Zou Y., Liang Y., Gong H., Zhou N., Ma H., Guan A., Sun A., Wang P., Niu Y., Jiang H., Takano H., Toko H., Yao A., Takeshima H., Akazawa H., Shiojima I., Wang Y., Komuro I., Ge J. Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy. Hypertension 2011, 58(6):1099-1110.
45. Kain V., Kumar S., Sitasawad S.L. Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis. Cardiovasc Diabetol 2011, 10:97.
46. Bonnefont-Rousselot D., Bastard J.P., Jaudon M.C., Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000, 26(3):163-176.
47. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40(4):405-412.
48. Jeremy J.Y., Yim A.P., Wan S., Angelini G.D. Oxidative stress, nitric oxide, and vascular disease. J Card Surg 2002, 17(4):324-327.
49. Can B., Ulusu N.N., Kilinc K., Leyla Acan N., Saran Y., Turan B. Selenium treatment protects diabetes-induced biochemical and ultrastructural alterations in liver tissue. Biol Trace Elem Res 2005, 105(1-3):135-150.
50. Battell M.L., Delgatty H.L., Mcneill J.H. Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats. Mol Cell Biochem 1998, 179(1-2):27-34.
51. Berg E.A., Wu J.Y., Campbell L., Kagey M., Stapleton S.R. Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats. Biochimie 1995, 77(12):919-924.
52. Kishimoto C., Shioji K., Nakamura H., Nakayama Y., Yodoi J., Sasayama S. Serum thioredoxin (trx) levels in patients with heart failure. Jpn Circ J 2001, 65(6):491-494.
53. Maulik N., Das D.K. Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions. Biochim Biophys Acta 2008, 1780(11):1368-1382.
54. Kiermayer C., Michalke B., Schmidt J., Brielmeier M. Effect of selenium on thioredoxin reductase activity in txnrd1 or txnrd2 hemizygous mice. Biol Chem 2007, 388(10):1091-1097.
55. Zheng Y., Zhong L., Shen X. Effect of selenium-supplement on the calcium signaling in human endothelial cells. J Cell Physiol 2005, 205(1):97-106.
56. Clark T.A., Maddaford T.G., Tappia P.S., Heyliger C.E., Ganguly P.K., Pierce G.N. Restoration of cardiomyocyte function in streptozotocin-induced diabetic rats after treatment with vanadate in a tea decoction. Curr Pharm Biotechnol 2010, 11(8):906-910.
57. Clark T.A., Heyliger C.E., Kopilas M., Edel A.L., Junaid A., Aguilar F., Smyth D.D., Thliveris J.A., Merchant M., Kim H.K., Pierce G.N. A tea/vanadate decoction delivered orally over 14 months to diabetic rats induces long-term glycemic stability without organ toxicity. Metabolism 2012, 61(5):742-753.
58. Heyliger C.E., Tahiliani A.G., Mcneill J.H. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 1985, 227(4693):1474-1477.
59. Miyamoto S., Kawano H., Hokamaki J., Soejima H., Kojima S., Kudoh T., Nagayoshi Y., Sugiyama S., Sakamoto T., Yoshimura M., Nakamura H., Yodoi J., Ogawa H. Increased plasma levels of thioredoxin in patients with glucose intolerance. Intern Med 2005, 44(11):1127-1132.
60. Liang M., Pietrusz J.L. Thiol-related genes in diabetic complications: a novel protective role for endogenous thioredoxin 2. Arterioscler Thromb Vasc Biol 2007, 27(1):77-83.
61. Packer L., Witt E.H., Tritschler H.J. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995, 19(2):227-250.
62. Mut M., Amos S., Hussaini I.M. Pkc alpha phosphorylates cytosolic nf-kappab/p65 and pkc delta delays nuclear translocation of nf-kappab/p65 in u1242 glioblastoma cells. Turk Neurosurg 2010, 20(3):277-285.